KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Medpace Holdings (MEDP) Cost of Revenue (2016 - 2026)

Medpace Holdings filings provide 12 years of Cost of Revenue readings, the most recent being $510.3 million for Q1 2026.

  • On a quarterly basis, Cost of Revenue rose 34.21% to $510.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.9 billion, a 28.61% increase, with the full-year FY2025 number at $1.8 billion, up 21.81% from a year prior.
  • Cost of Revenue hit $510.3 million in Q1 2026 for Medpace Holdings, up from $503.1 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $510.3 million in Q1 2026 to a low of $232.3 million in Q1 2022.
  • Median Cost of Revenue over the past 5 years was $359.3 million (2023), compared with a mean of $360.1 million.
  • Biggest five-year swings in Cost of Revenue: dropped 0.92% in 2024 and later soared 40.43% in 2025.
  • Medpace Holdings' Cost of Revenue stood at $278.4 million in 2022, then grew by 29.9% to $361.6 million in 2023, then fell by 0.92% to $358.3 million in 2024, then soared by 40.43% to $503.1 million in 2025, then grew by 1.42% to $510.3 million in 2026.
  • The last three reported values for Cost of Revenue were $510.3 million (Q1 2026), $503.1 million (Q4 2025), and $463.0 million (Q3 2025) per Business Quant data.